Tert-butyl 4-hydroxypiperidine-1-carboxylate → tert-Butyl 4-((6-chloropyridin-3-yl)methoxy)piperidine-1-carboxylate
Reaktionsgleichung
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([OH:14])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].CS(O[CH2:20][C:21]1[CH:22]=[N:23][C:24]([Cl:27])=[CH:25][CH:26]=1)(=O)=O>>[Cl:27][C:24]1[N:23]=[CH:22][C:21]([CH2:20][O:14][CH:11]2[CH2:12][CH2:13][N:8]([C:6]([O:5][C:1]([CH3:4])([CH3:2])[CH3:3])=[O:7])[CH2:9][CH2:10]2)=[CH:26][CH:25]=1Komponenten
3
Versuchsvorschrift
The title compound was prepared by following the similar procedure as described in Intermediate-42 using 4-hydroxy-piperidine-1-carboxylic acid tert-butyl ester and (6-chloropyridin-3-yl)methyl methanesulfonate; MS: 227 (M−100).
Quellen und Nachweise
- ORD-Eintrag
- ord-3563e2de9ec64eb0a24ff58d73401c08
- Quelldatensatz
- uspto-grants-2015_04
- Patentnummer
- US09000175B2
Notizen zur Reaktion
Wird geladen…